Sands Capital
Sands Capital International Growth
International Growth
Jun 2025 → Dec 2025
Our archive holds 3 letters from this strategy, behind 4 investment theses and positions in 4 companies. Every quote below is copied verbatim from the letter it came from.
3 letters in a year — follow all of Sands Capital for every strategy.
Its investment theses
- EssilorLuxotticaDec 2025EssilorLuxottica is a vertically integrated eyewear leader with pricing power, innovation, and new growth drivers like smart glasses.
- ArgenxSep 2025Argenx is advancing targeted antibody therapies for autoimmune diseases, with its first product Vyvgart showing significant growth potential and a strong market position.
- Nu HoldingsJul 2025Nu Holdings is a digital financial services platform, Nubank, that leverages its competitive advantages to disrupt the underbanked Latin American market, targeting customer acquisition and monetization for growth.
- GaldermaJun 2025Galderma is a leading Swiss dermatology company positioned for long-term above-average earnings growth due to its strong market presence, innovative products, and focus on high-margin injectables and therapeutics.